These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 1400868

  • 1. Skeletal responsiveness to endogenous parathyroid hormone in postmenopausal osteoporosis.
    Ebeling PR, Jones JD, Burritt MF, Duerson CR, Lane AW, Hassager C, Kumar R, Riggs BL.
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1033-8. PubMed ID: 1400868
    [Abstract] [Full Text] [Related]

  • 2. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F, Ahmad AM, Ul-Haq M, Durham BH, Whittingham P, Fraser WD, Vora JP.
    J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Resistance to bone resorbing effects of PTH in black women.
    Cosman F, Morgan DC, Nieves JW, Shen V, Luckey MM, Dempster DW, Lindsay R, Parisien M.
    J Bone Miner Res; 1997 Jun; 12(6):958-66. PubMed ID: 9169356
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis.
    Sugimoto T, Nakamura T, Nakamura Y, Isogai Y, Shiraki M.
    Osteoporos Int; 2014 Mar; 25(3):1173-80. PubMed ID: 24108429
    [Abstract] [Full Text] [Related]

  • 9. Calcium supplementation suppresses bone turnover during weight reduction in postmenopausal women.
    Ricci TA, Chowdhury HA, Heymsfield SB, Stahl T, Pierson RN, Shapses SA.
    J Bone Miner Res; 1998 Jun; 13(6):1045-50. PubMed ID: 9626637
    [Abstract] [Full Text] [Related]

  • 10. Effects of short-term calcium depletion and repletion on biochemical markers of bone turnover in young adult women.
    Akesson K, Lau KH, Johnston P, Imperio E, Baylink DJ.
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1921-7. PubMed ID: 9626120
    [Abstract] [Full Text] [Related]

  • 11. Effects of the circadian variation in serum cortisol on markers of bone turnover and calcium homeostasis in normal postmenopausal women.
    Heshmati HM, Riggs BL, Burritt MF, McAlister CA, Wollan PC, Khosla S.
    J Clin Endocrinol Metab; 1998 Mar; 83(3):751-6. PubMed ID: 9506720
    [Abstract] [Full Text] [Related]

  • 12. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B, Kirmaz C, Aydin K, Kafesciler SO, Guclu F, Hekimsoy Z.
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [Abstract] [Full Text] [Related]

  • 13. Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosis.
    Fraser WD, Logue FC, Christie JP, Gallacher SJ, Cameron D, O'Reilly DS, Beastall GH, Boyle IT.
    Osteoporos Int; 1998 Sep; 8(2):121-6. PubMed ID: 9666934
    [Abstract] [Full Text] [Related]

  • 14. Bone responsiveness to parathyroid hormone in normal and osteoporotic postmenopausal women.
    Tsai KS, Ebeling PR, Riggs BL.
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1024-7. PubMed ID: 2793989
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: a dose response study.
    Brixen K, Kassem M, Nielsen HK, Loft AG, Flyvbjerg A, Mosekilde L.
    J Bone Miner Res; 1995 Dec; 10(12):1865-74. PubMed ID: 8619366
    [Abstract] [Full Text] [Related]

  • 17. Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis.
    Lane NE, Sanchez S, Genant HK, Jenkins DK, Arnaud CD.
    Osteoporos Int; 2000 Dec; 11(5):434-42. PubMed ID: 10912846
    [Abstract] [Full Text] [Related]

  • 18. Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes.
    Yamamoto M, Yamaguchi T, Nawata K, Yamauchi M, Sugimoto T.
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1277-84. PubMed ID: 22337915
    [Abstract] [Full Text] [Related]

  • 19. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M, Inaba M, Okuno S, Maeno Y, Ishimura E, Yamakawa T, Nishizawa Y.
    Life Sci; 2005 Jul 22; 77(10):1130-9. PubMed ID: 15978265
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.